REGENERON PHARMACEUTICALS, INC.
REGENERON PHARMACEUTICALS, INC. is a Private limited company (Ltd.) registered in United States under 1226128, and its current status with New York Department of State — Division of Corporations is active. The company was incorporated on 11 January 1988 and lists its registered address as Tarrytown, United States. 3 shareholders are on record for REGENERON PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New York Department of State — Division of Corporations and was last updated on 22 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
3
Shareholders of REGENERON PHARMACEUTICALS, INC.
Three shareholders are currently on record for REGENERON PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 14.3% — the largest recorded stake — followed by SPDR S&P 500 ETF TRUST at 1.9%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Officers
5
Directors and officers of REGENERON PHARMACEUTICALS, INC.
The Director of REGENERON PHARMACEUTICALS, INC. on record is Huda Y. Zoghbi; 5 officers are shown here, filed with New York Department of State — Division of Corporations. Management authority at REGENERON PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 48 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Group Structure
Group structure of REGENERON PHARMACEUTICALS, INC.
REGENERON PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 14 subsidiaries recorded beneath it across 4 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Loop Road Holdings LLC (United States)
- Osmr Holdings (Bermuda)
- Rock County Holdings LLC (United States)
- Regeneron Healthcare Solutions, Inc. (United States)
- Old Saw Mill Holdings LLC (United States)
- Eastside Campus Holdings LLC (United States)
- Regeneron Assurance, Inc. (United States)
- Checkmate Pharmaceuticals, Inc. (United States)
- Regeneron International Holdings, LLC (United States)
- REGENERON JAPAN INC. (Japan)
Data availability
Those 14 subsidiaries span United States, Bermuda, Japan, Belgium jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 14 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns REGENERON PHARMACEUTICALS, INC.?
Three shareholders are currently on record for REGENERON PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 14.3% — the largest recorded stake — followed by SPDR S&P 500 ETF TRUST at 1.9%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is REGENERON PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for REGENERON PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does REGENERON PHARMACEUTICALS, INC. have on record?
3 shareholders are shown on record for REGENERON PHARMACEUTICALS, INC..
What is REGENERON PHARMACEUTICALS, INC.'s company registration number?
REGENERON PHARMACEUTICALS, INC.'s registration number is 1226128, filed with New York Department of State — Division of Corporations in United States. Its current status on the register is active.
Is REGENERON PHARMACEUTICALS, INC. still an active company?
REGENERON PHARMACEUTICALS, INC.'s status on New York Department of State — Division of Corporations is listed as active.
When was REGENERON PHARMACEUTICALS, INC. incorporated?
REGENERON PHARMACEUTICALS, INC. was incorporated on 11 January 1988, according to New York Department of State — Division of Corporations.
What is REGENERON PHARMACEUTICALS, INC.'s registered address?
The registered address on file for REGENERON PHARMACEUTICALS, INC. is Tarrytown, United States.
What legal structure is REGENERON PHARMACEUTICALS, INC. registered as?
REGENERON PHARMACEUTICALS, INC. is registered as a Private limited company (Ltd.) in United States.
Who are the officers/directors of REGENERON PHARMACEUTICALS, INC.?
The Director of REGENERON PHARMACEUTICALS, INC. on record is Huda Y. Zoghbi; 5 officers are shown here, filed with New York Department of State — Division of Corporations. Management authority at REGENERON PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does REGENERON PHARMACEUTICALS, INC. have a parent company or subsidiaries?
REGENERON PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 14 subsidiaries recorded beneath it across 4 jurisdictions. Those 14 subsidiaries span United States, Bermuda, Japan, Belgium jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 14 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to REGENERON PHARMACEUTICALS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from New York Department of State — Division of Corporations. Zavia's monitoring API can track changes to REGENERON PHARMACEUTICALS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access REGENERON PHARMACEUTICALS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like REGENERON PHARMACEUTICALS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from New York Department of State — Division of Corporations and was last synced on 22 September 2026.